Editorial: Women in pharmacology of anti-cancer drugs: 2021

por Giovannetti, Elisa
Publicado 2022

MicroRNAs in Cancer Management: Big Challenges for Small Molecules

por Gandellini, Paolo, Giovannetti, Elisa, Nicassio, Francesco
Publicado 2015

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets

por Cavallari, Ilaria, Cerciello, Ferdinando, Giovannetti, Elisa, Urso, Loredana
Publicado 2023

New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway

por Alfieri, Roberta, Giovannetti, Elisa, Bonelli, Mara, Cavazzoni, Andrea
Publicado 2017

PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition

por Cretella, Daniele, Digiacomo, Graziana, Giovannetti, Elisa, Cavazzoni, Andrea
Publicado 2019

c-Met as a Target for Personalized Therapy

por Garajová, Ingrid, Giovannetti, Elisa, Biasco, Guido, Peters, Godefridus J.
Publicado 2015

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

por Ciccolini, Joseph, Serdjebi, Cindy, Peters, Godefridus J., Giovannetti, Elisa
Publicado 2016

Role of Akt signaling in resistance to DNA-targeted therapy

por Avan, Abolfazl, Narayan, Ravi, Giovannetti, Elisa, Peters, Godefridus J
Publicado 2016

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

por Peters, Godefridus J., Giovannetti, Elisa, Honeywell, Richard J., Ciccolini, Joseph
Publicado 2019

Novel Strategies to Address Critical Challenges in Pancreatic Cancer

por Puik, Jisce R., Swijnenburg, Rutger-Jan, Kazemier, Geert, Giovannetti, Elisa
Publicado 2022

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma

por Vahabi, Mahrou, Dehni, Bilal, Antomás, Inés, Giovannetti, Elisa, Peters, Godefridus J.
Publicado 2023

USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy

por García-Santisteban, Iraia, Peters, Godefridus J, Giovannetti, Elisa, Rodríguez, Jose Antonio
Publicado 2013

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer

por Rolfo, Christian, Giovannetti, Elisa, Martinez, Pablo, McCue, Shannon, Naing, Aung
Publicado 2023

Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance

por Jiang, Yaling, Donati, Valentina, Peters, Godefridus J., Giovannetti, Elisa, Deng, Dong Mei
Publicado 2023

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

por Muller, Ittai B, de Langen, Adrianus J, Giovannetti, Elisa, Peters, Godefridus J
Publicado 2017

Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation

por Holst, Stephanie, Belo, Ana I., Giovannetti, Elisa, van Die, Irma, Wuhrer, Manfred
Publicado 2017

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

por Leonetti, Alessandro, Sharma, Sugandhi, Minari, Roberta, Perego, Paola, Giovannetti, Elisa, Tiseo, Marcello
Publicado 2019

CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage

por El Hassouni, Btissame, Mantini, Giulia, Immordino, Benoît, Peters, Godefridus J., Giovannetti, Elisa
Publicado 2019

hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

por Meijer, Laura L., Puik, Jisce R., Peters, Godefridus J., Kazemier, Geert, Giovannetti, Elisa
Publicado 2016

Of fungi and men: role of fungi in pancreatic cancer carcinogenesis

por Wang, Heling, Capula, Mjriam, Krom, Bastiaan P., Yee, Dicky, Giovannetti, Elisa, Deng, Dongmei
Publicado 2020